HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Modulation of acute and chronic inflammatory processes by a traditional medicine preparation GCSB-5 both in vitro and in vivo animal models.

AbstractAIM OF THIS STUDY:
GCSB-5 is a traditional medicine preparation composed with six oriental herbs which have been widely used for the inflammatory diseases in Asia. In the present study, we have demonstrated the anti-inflammatory effects of GCSB-5 in vivo and in vitro along with its underlying mechanism of action.
METHODS:
The acute and chronic inflammation models in animals were applied to investigate the anti-inflammatory effects of GCSB-5. To further investigate the mechanism of the anti-inflammatory activity, lipopolysaccharide (LPS)-induced murine macrophage RAW264.7 cells were also employed.
RESULTS:
In in vivo animal model, oral administration of GCSB-5 significantly inhibited TPA- and carrageenan-induced acute edema and adjuvant-induced arthritis. The vascular permeability, leukocyte migration, and granuloma formation were also inhibited by GCSB-5. In accordance, GCSB-5 suppressed the LPS-induced nitric oxide (NO) production by the downregulation of mRNA and protein expressions of inducible nitric oxide synthase (iNOS). GCSB-5 also suppressed the expressions of cyclooxygenase-2 (COX-2) and inflammatory cytokines such as interleukin-1beta and interferon-beta. The activation of NF-kappaB by LPS was also alleviated by GCSB-5, which correlated with its inhibitory effect on IkB degradation. The signaling pathway with the activation of Akt was also attenuated by the treatment by GCSB-5.
CONCLUSIONS:
Taken together, our results demonstrate that GCSB-5 reduces the development of acute and chronic inflammation and its anti-inflammatory property might in part be a function of the inhibition of iNOS and COX-2 expression via down-regulation of the Akt signal pathway and inhibition of NF-kappaB activation. These findings suggest that GCSB-5 might be an applicable therapeutic traditional medicine in the regulation of the inflammatory response.
AuthorsHwa-Jin Chung, Hak-Sun Lee, Joon-Shik Shin, Sang-Ho Lee, Byung-Mo Park, You-Suk Youn, Sang Kook Lee
JournalJournal of ethnopharmacology (J Ethnopharmacol) Vol. 130 Issue 3 Pg. 450-9 (Aug 09 2010) ISSN: 1872-7573 [Electronic] Ireland
PMID20621661 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2010 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Anti-Inflammatory Agents
  • NF-kappa B
  • Plant Extracts
  • Nitric Oxide Synthase Type II
  • Cyclooxygenase 2
  • Proto-Oncogene Proteins c-akt
Topics
  • Acute Disease
  • Animals
  • Anti-Inflammatory Agents (pharmacology)
  • Cell Line
  • Chronic Disease
  • Cyclooxygenase 2 (drug effects, genetics)
  • Disease Models, Animal
  • Inflammation (drug therapy, physiopathology)
  • Macrophages (drug effects, metabolism)
  • Male
  • Medicine, East Asian Traditional
  • Mice
  • Mice, Inbred ICR
  • NF-kappa B (antagonists & inhibitors)
  • Nitric Oxide Synthase Type II (drug effects, genetics)
  • Phytotherapy (methods)
  • Plant Extracts (pharmacology)
  • Proto-Oncogene Proteins c-akt (drug effects, metabolism)
  • Rats
  • Rats, Sprague-Dawley

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: